Related Links

Click here to go directly to the members only pages of the Health and Medicines Information Section.

Continuing Education

Click above to download the Counseling, Concordance, Communication booklet jointly produced with IPSF


Pharmabridge aims to strengthen pharmaceutical services and pharmacy education in developing and transitional countries. Click here to read more.

Health and Medicines Information Section


The Health and Medicines Information Section was founded in Rome in 1951 at the 14th FIP General assembly.

The section offers:

  • a forum to share knowledge about information issues relating to pharmacy, medicines, diseases and health, including public health;
  • avenues for networking between groups that provide information services to patients and healthcare professionals;
  • avenues for networking between groups that research in the area of health and medicine information;
  • opportunities to enhance public health and the work of the profession of pharmacy through information programs and related initiatives.

Current areas of interest

  • Information needs for optimum patient care, pharmaceutical care and public health
  • Use of health and medicine information to promote adherence to therapy
  • Development of health information technology and delivery
  • Writing and publishing health information resources
  • Medicine and poisons information services
  • Global access to healthcare information
  • Advertising and promotion of medicines
  • Strategic development of medicines information

The Section also organises and contributes to FIP congress programs. In 2012, topics included:

  • partnering with patients to improve medicines information
  • the effectiveness of medicines information to improve optimal use of medicines
  • responsible use of OTC medicines through labelling and counselling
  • medication reviews
  • safety of medicines through pharmacovigilance

Topics for future FIP congresses:

What we can learn from real world patient data:

  • Health care data and confidentiality
  • Why better communication is necessary
  • Complex patients view on obstacles to quality use of medicines
  • Preserving scientific knowledge across languages
  • How to preserve freedom of choice in automated medication surveillance

Future activities and programs will be guided by FIP's 2020 Vision

Executive Committee
Officers of the Section are elected every four years and include a President, Secretary and Treasurer. The Executive Committee consists of the three officers, the past president, and three to six section members elected to provide geographical balance (current ExCo).

In December 2012, the section included members from 70 countries:
Albania, Argentina, Australia, Austria, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Cameroon, Canada, Chad, Congo (Rep. of), Costa Rica, Croatia, Czech Republic, Denmark, Denmark (Færoe Islands), Egypt, Finland, France,  France (Guadeloupe), Germany, Ghana, Greece, Honduras, Iceland, India, Indonesia, Iran, Iraq, Ireland, Italy, Japan, Jordan, Kenya, Korea (Rep. of), Kuwait, Latvia, Lebanon, Malta, Mexico, Moldova, Nepal, Netherlands, Netherlands (Netherlands Antilles), Nigeria, Norway, Pakistan, Papua New Guinea, Peru, Philippines, Portugal, Russian Federation, Rwanda, Saudi Arabia, Serbia (Rep. of), Singapore, South Africa, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States, Zimbabwe.